Agilon Health (NYSE:AGL) reported quarterly earnings of $2.94 per share which beat the analyst consensus estimate of $1.31 by 124.43 percent. The company reported quarterly sales of $1.420 billion which beat the analyst consensus estimate of $1.380 billion by 2.93 percent. This is a 7.33 percent decrease over sales of $1.533 billion the same period last year.